Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 5/20 | 0.87 |
| ▸ | GAA | P10253 | 1/20 | 0.79 |
| ▸ | MEN1 | O00255 | 1/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.77 |
| ▸ | FAAH | O00519 | 2/20 | 0.73 |
| ▸ | POLB | P06746 | 1/20 | 0.72 |
| ▸ | HPGD | P15428 | 2/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.71 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.71 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.71 |
| ▸ | CNR1 | P21554 | 1/20 | 0.69 |
| ▸ | CNR2 | P34972 | 1/20 | 0.69 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.68 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.65 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.65 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.65 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.65 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.65 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1516109 | 0.95 | EPHX2 (0.97) | EPHX2GAAMEN1KMT2AFAAH | |
| SCHEMBL29052372 | 0.93 | EPHX2 (1.00) | EPHX2GAAMEN1KMT2AFAAH | |
| SCHEMBL5471650 | 0.93 | EPHX2 (1.00) | EPHX2GAAMEN1KMT2AFAAH | |
| SCHEMBL2088173 | 0.93 | EPHX2 (1.00) | EPHX2GAAMEN1KMT2AFAAH | |
| SCHEMBL2524088 | 0.93 | EPHX2 (1.00) | EPHX2GAAMEN1KMT2AFAAH | |
| N-Benzyldodecanamide SCHEMBL3977374 | 0.93 | EPHX2 (1.00) | EPHX2GAAMEN1KMT2AFAAH | |
| SCHEMBL5696750 | 0.93 | EPHX2 (1.00) | EPHX2GAAMEN1KMT2AFAAH | |
| SCHEMBL16714726 | 0.93 | EPHX2 (1.00) | EPHX2GAAMEN1KMT2AFAAH | |
| Nonanoic Acid Benzylamide SCHEMBL3280214 | 0.93 | EPHX2 (1.00) | EPHX2GAAMEN1KMT2AFAAH | |
| SCHEMBL2166861 | 0.93 | EPHX2 (1.00) | EPHX2GAAMEN1KMT2AFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002028829-A2 | PEPTIDE DEFORMYLASE INHIBITORS | QUESTCOR PHARMACEUTICALS, INC. (US) | 2002-04-11 | — | — | WO | claimed |
| CN-117328066-B | Coarsening microetching agent for circuit board and preparation method thereof | 江苏贺鸿电子有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117328066-A | Coarsening microetching agent for circuit board and preparation method thereof | 江苏贺鸿电子有限公司 | 2024-01-02 | — | — | CN | disclosed |
| WO-2023091674-A1 | INHIBITORS OF THE ONCOGENIC SHP2 PHOSPHATASE AND USES THEREOF | Sanford Burnham Prebys Medical Discovery Institute (US) | 2023-05-25 | — | — | WO | disclosed |
| WO-2021161099-A1 | PROCESS FOR THE SYNTHESIS OF S-BEFLUBUTAMID FROM (R)-2-AMINOBUTANOIC ACID | CHEMINOVA A/S (DK) | 2021-08-19 | — | — | WO | disclosed |
| CN-105814038-B | Benzimidazole derivatives as EP4 ligands | 拜耳医药股份公司 | 2018-12-04 | — | — | CN | disclosed |
| CN-104969406-B | Electrolyte solution for electrochemical device and electrochemical device | 富士胶片和光纯药株式会社 | 2018-11-02 | — | — | CN | disclosed |
| EP-3083603-B1 | BENZIMIDAZOLYL DERIVATIVES AS EP4 LIGANDS | Bayer Pharma AG (DE) | 2017-09-13 | — | — | EP | disclosed |
| US-9738685-B2 | Use of ruthenium complexes for preparing amides, polypeptides and cyclic dipeptides | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2017-08-22 | — | — | US | disclosed |
| US-9738685-B2 | Use of ruthenium complexes for preparing amides, polypeptides and cyclic dipeptides | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2017-08-22 | — | — | US | disclosed |
| US-5886014-A | TREATMENT AND/OR PROPHYLAXIS OF A VARIETY OF DISORDERS, INCLUDING HYPERLIPEMIA, HYPERGLYCEMIA, OBESITY, IMPAIRED GLUCOSE TOLERANCE (IGT), INSULIN RESISTANCE AND DIABETIC COMPLICATIONS | SANKYO COMPANY, LIMITED (JP) | 1999-03-23 | — | — | US | disclosed |
| US-5834501-A | TREATING DIABETES OR HYPERLIPEMIA | SANKYO COMPANY, LIMITED (JP) | 1998-11-10 | — | — | US | disclosed |
| WO-1998037079-A1 | N-HETEROCYCLIC DERIVATIVES AS NOS INHIBITORS | BERLEX LABORATORIES, INC. (US) | 1998-08-27 | — | — | WO | disclosed |
| US-5739345-A | HYPOGLYCEMIC AND ANTIDIABETIC AGENTS | SANKYO COMPANY, LIMITED (JP) | 1998-04-14 | — | — | US | disclosed |
| US-5624935-A | ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS | SANKYO COMPANY, LIMITED | 1997-04-29 | — | — | US | disclosed |
| CN-1118781-A | Heterocyclic compound with activity against diabetes and preparation and application of same | MITSUTAKA CO LTD (JP) | 1996-03-20 | — | — | CN | disclosed |
| EP-0676398-A2 | Heterocyclic compounds having anti-diabetic activity, their preparation and their use | SANKYO COMPANY LIMITED (JP) | 1995-10-11 | — | — | EP | disclosed |
| EP-0258289-A4 | PEPTIDE ANALOGS | — | 1991-01-02 | — | — | EP | disclosed |
| EP-0258289-A1 | PEPTIDE ANALOGS | ABBOTT LABORATORIES (US) | 1988-03-09 | — | — | EP | disclosed |
| WO-1987004349-A1 | PEPTIDE ANALOGS | DELLARIA JOSEPH | 1987-07-30 | — | — | WO | disclosed |